APO Research
Talk to an analyst

APO RESEARCH · REPORT

Osimertinib Mesylate Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Osimertinib Mesylate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025181 pages

Choose your research edition.

Industry ResearchOsimertinib Mesylate Tablets Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Osimertinib Mesylate Tablets Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Osimertinib Mesylate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osimertinib Mesylate Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Osimertinib Mesylate Tablets Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Osimertinib Mesylate Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Osimertinib Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Osimertinib Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Osimertinib Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Osimertinib Mesylate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Osimertinib Mesylate Tablets include Wanbang Biopharmaceuticals, AstraZeneca, Zydus, Pharmacil, General Pharmaceuticals, Drug International and Beacon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Osimertinib Mesylate Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Osimertinib Mesylate Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Osimertinib Mesylate Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Osimertinib Mesylate Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Osimertinib Mesylate Tablets Segment by Company

Wanbang Biopharmaceuticals

AstraZeneca

Zydus

Pharmacil

General Pharmaceuticals

Drug International

Beacon

Osimertinib Mesylate Tablets Segment by Type

Original Drug

Generic Drug

Osimertinib Mesylate Tablets Segment by Application

Retail Pharmacies

Hospital and Clinic

Other

Osimertinib Mesylate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osimertinib Mesylate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osimertinib Mesylate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osimertinib Mesylate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Osimertinib Mesylate Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Osimertinib Mesylate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Osimertinib Mesylate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Osimertinib Mesylate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Osimertinib Mesylate Tablets Industry Trends Table 2. Osimertinib Mesylate Tablets Industry Drivers Table 3. Osimertinib Mesylate Tablets Industry Opportunities and Challenges Table 4. Osimertinib Mesylate Tablets Industry Restraints Table 5. Global Osimertinib Mesylate Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Osimertinib Mesylate Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Osimertinib Mesylate Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Osimertinib Mesylate Tablets Sales Market Share by Manufacturers Table 9. Global Osimertinib Mesylate Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Osimertinib Mesylate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Osimertinib Mesylate Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Osimertinib Mesylate Tablets Manufacturers, Product Type & Application Table 13. Global Osimertinib Mesylate Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Osimertinib Mesylate Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Original Drug Table 17. Major Manufacturers of Generic Drug Table 18. Global Osimertinib Mesylate Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Osimertinib Mesylate Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Osimertinib Mesylate Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Osimertinib Mesylate Tablets Sales Market Share by Type (2021-2026) Table 22. Global Osimertinib Mesylate Tablets Sales Market Share by Type (2027-2032) Table 23. Global Osimertinib Mesylate Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Osimertinib Mesylate Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Osimertinib Mesylate Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Osimertinib Mesylate Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Osimertinib Mesylate Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Retail Pharmacies Table 29. Major Manufacturers of Hospital and Clinic Table 30. Major Manufacturers of Other Table 31. Global Osimertinib Mesylate Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Osimertinib Mesylate Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Osimertinib Mesylate Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Osimertinib Mesylate Tablets Sales Market Share by Application (2021-2026) Table 35. Global Osimertinib Mesylate Tablets Sales Market Share by Application (2027-2032) Table 36. Global Osimertinib Mesylate Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Osimertinib Mesylate Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Osimertinib Mesylate Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Osimertinib Mesylate Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Osimertinib Mesylate Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Osimertinib Mesylate Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Osimertinib Mesylate Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Osimertinib Mesylate Tablets Sales Market Share by Region (2021-2026) Table 44. Global Osimertinib Mesylate Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Osimertinib Mesylate Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Osimertinib Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Osimertinib Mesylate Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Osimertinib Mesylate Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Osimertinib Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Osimertinib Mesylate Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Osimertinib Mesylate Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Osimertinib Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Osimertinib Mesylate Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Osimertinib Mesylate Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Osimertinib Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Osimertinib Mesylate Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Osimertinib Mesylate Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Osimertinib Mesylate Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Osimertinib Mesylate Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Osimertinib Mesylate Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Osimertinib Mesylate Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Osimertinib Mesylate Tablets Revenue Market Share by Region (2027-2032) Table 63. Wanbang Biopharmaceuticals Company Information Table 64. Wanbang Biopharmaceuticals Business Overview Table 65. Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Product Portfolio Table 67. Wanbang Biopharmaceuticals Recent Development Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Osimertinib Mesylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. AstraZeneca Osimertinib Mesylate Tablets Product Portfolio Table 72. AstraZeneca Recent Development Table 73. Zydus Company Information Table 74. Zydus Business Overview Table 75. Zydus Osimertinib Mesylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Zydus Osimertinib Mesylate Tablets Product Portfolio Table 77. Zydus Recent Development Table 78. Pharmacil Company Information Table 79. Pharmacil Business Overview Table 80. Pharmacil Osimertinib Mesylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Pharmacil Osimertinib Mesylate Tablets Product Portfolio Table 82. Pharmacil Recent Development Table 83. General Pharmaceuticals Company Information Table 84. General Pharmaceuticals Business Overview Table 85. General Pharmaceuticals Osimertinib Mesylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. General Pharmaceuticals Osimertinib Mesylate Tablets Product Portfolio Table 87. General Pharmaceuticals Recent Development Table 88. Drug International Company Information Table 89. Drug International Business Overview Table 90. Drug International Osimertinib Mesylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Drug International Osimertinib Mesylate Tablets Product Portfolio Table 92. Drug International Recent Development Table 93. Beacon Company Information Table 94. Beacon Business Overview Table 95. Beacon Osimertinib Mesylate Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Beacon Osimertinib Mesylate Tablets Product Portfolio Table 97. Beacon Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Osimertinib Mesylate Tablets Distributors List Table 101. Osimertinib Mesylate Tablets Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Osimertinib Mesylate Tablets Product Image Figure 2. Global Osimertinib Mesylate Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Osimertinib Mesylate Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Osimertinib Mesylate Tablets Sales (2021-2032) & (K Units) Figure 5. Global Osimertinib Mesylate Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Osimertinib Mesylate Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Original Drug Image Figure 9. Generic Drug Image Figure 10. Global Osimertinib Mesylate Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Osimertinib Mesylate Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Osimertinib Mesylate Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Osimertinib Mesylate Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Osimertinib Mesylate Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Osimertinib Mesylate Tablets Revenue Market Share by Type (2021-2032) Figure 16. Retail Pharmacies Image Figure 17. Hospital and Clinic Image Figure 18. Other Image Figure 19. Global Osimertinib Mesylate Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Osimertinib Mesylate Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Osimertinib Mesylate Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Osimertinib Mesylate Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Osimertinib Mesylate Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Osimertinib Mesylate Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Osimertinib Mesylate Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Osimertinib Mesylate Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Osimertinib Mesylate Tablets Sales Market Share by Country (2021-2032) Figure 39. China Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Osimertinib Mesylate Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Osimertinib Mesylate Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Osimertinib Mesylate Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Osimertinib Mesylate Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Osimertinib Mesylate Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Osimertinib Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Osimertinib Mesylate Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Osimertinib Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Osimertinib Mesylate Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Osimertinib Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Osimertinib Mesylate Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Osimertinib Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Osimertinib Mesylate Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Osimertinib Mesylate Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Retail Pharmacies
  • Hospital and Clinic
  • Other
Companies covered
  • Wanbang Biopharmaceuticals
  • AstraZeneca
  • Zydus
  • Pharmacil
  • General Pharmaceuticals
  • Drug International
  • Beacon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Osimertinib Mesylate Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Osimertinib Mesylate Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Osimertinib Mesylate Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Osimertinib Mesylate Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Osimertinib Mesylate Tablets Market Dynamics
  1. 2.1 Osimertinib Mesylate Tablets Industry Trends
  2. 2.2 Osimertinib Mesylate Tablets Industry Drivers
  3. 2.3 Osimertinib Mesylate Tablets Industry Opportunities and Challenges
  4. 2.4 Osimertinib Mesylate Tablets Industry Restraints
3 Osimertinib Mesylate Tablets Market by Manufacturers
  1. 3.1 Global Osimertinib Mesylate Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Osimertinib Mesylate Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Osimertinib Mesylate Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Osimertinib Mesylate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Osimertinib Mesylate Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Osimertinib Mesylate Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Osimertinib Mesylate Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Osimertinib Mesylate Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Osimertinib Mesylate Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Osimertinib Mesylate Tablets Tier 1, Tier 2, and Tier 3
4 Osimertinib Mesylate Tablets Market by Type
  1. 4.1 Osimertinib Mesylate Tablets Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Osimertinib Mesylate Tablets Sales by Type
  5. 4.2.1 Global Osimertinib Mesylate Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Osimertinib Mesylate Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Osimertinib Mesylate Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Osimertinib Mesylate Tablets Revenue by Type
  9. 4.3.1 Global Osimertinib Mesylate Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Osimertinib Mesylate Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Osimertinib Mesylate Tablets Revenue Market Share by Type (2021-2032)
5 Osimertinib Mesylate Tablets Market by Application
  1. 5.1 Osimertinib Mesylate Tablets Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Other
  5. 5.2 Global Osimertinib Mesylate Tablets Sales by Application
  6. 5.2.1 Global Osimertinib Mesylate Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Osimertinib Mesylate Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Osimertinib Mesylate Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Osimertinib Mesylate Tablets Revenue by Application
  10. 5.3.1 Global Osimertinib Mesylate Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Osimertinib Mesylate Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Osimertinib Mesylate Tablets Revenue Market Share by Application (2021-2032)
6 Global Osimertinib Mesylate Tablets Sales by Region
  1. 6.1 Global Osimertinib Mesylate Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Osimertinib Mesylate Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Osimertinib Mesylate Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Osimertinib Mesylate Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Osimertinib Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Osimertinib Mesylate Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Osimertinib Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Osimertinib Mesylate Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Osimertinib Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Osimertinib Mesylate Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Osimertinib Mesylate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Osimertinib Mesylate Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Osimertinib Mesylate Tablets Revenue by Region
  1. 7.1 Global Osimertinib Mesylate Tablets Revenue by Region
  2. 7.1.1 Global Osimertinib Mesylate Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Osimertinib Mesylate Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Osimertinib Mesylate Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Osimertinib Mesylate Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Osimertinib Mesylate Tablets Revenue (2021-2032)
  8. 7.2.2 North America Osimertinib Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Osimertinib Mesylate Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Osimertinib Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Osimertinib Mesylate Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Osimertinib Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Osimertinib Mesylate Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Osimertinib Mesylate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Wanbang Biopharmaceuticals
  2. 8.1.1 Wanbang Biopharmaceuticals Company Information
  3. 8.1.2 Wanbang Biopharmaceuticals Business Overview
  4. 8.1.3 Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Product Portfolio
  6. 8.1.5 Wanbang Biopharmaceuticals Recent Developments
  7. 8.2 AstraZeneca
  8. 8.2.1 AstraZeneca Company Information
  9. 8.2.2 AstraZeneca Business Overview
  10. 8.2.3 AstraZeneca Osimertinib Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AstraZeneca Osimertinib Mesylate Tablets Product Portfolio
  12. 8.2.5 AstraZeneca Recent Developments
  13. 8.3 Zydus
  14. 8.3.1 Zydus Company Information
  15. 8.3.2 Zydus Business Overview
  16. 8.3.3 Zydus Osimertinib Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zydus Osimertinib Mesylate Tablets Product Portfolio
  18. 8.3.5 Zydus Recent Developments
  19. 8.4 Pharmacil
  20. 8.4.1 Pharmacil Company Information
  21. 8.4.2 Pharmacil Business Overview
  22. 8.4.3 Pharmacil Osimertinib Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pharmacil Osimertinib Mesylate Tablets Product Portfolio
  24. 8.4.5 Pharmacil Recent Developments
  25. 8.5 General Pharmaceuticals
  26. 8.5.1 General Pharmaceuticals Company Information
  27. 8.5.2 General Pharmaceuticals Business Overview
  28. 8.5.3 General Pharmaceuticals Osimertinib Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 General Pharmaceuticals Osimertinib Mesylate Tablets Product Portfolio
  30. 8.5.5 General Pharmaceuticals Recent Developments
  31. 8.6 Drug International
  32. 8.6.1 Drug International Company Information
  33. 8.6.2 Drug International Business Overview
  34. 8.6.3 Drug International Osimertinib Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Drug International Osimertinib Mesylate Tablets Product Portfolio
  36. 8.6.5 Drug International Recent Developments
  37. 8.7 Beacon
  38. 8.7.1 Beacon Company Information
  39. 8.7.2 Beacon Business Overview
  40. 8.7.3 Beacon Osimertinib Mesylate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Beacon Osimertinib Mesylate Tablets Product Portfolio
  42. 8.7.5 Beacon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Osimertinib Mesylate Tablets Value Chain Analysis
  2. 9.1.1 Osimertinib Mesylate Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Osimertinib Mesylate Tablets Production Mode & Process
  6. 9.2 Osimertinib Mesylate Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Osimertinib Mesylate Tablets Distributors
  9. 9.2.3 Osimertinib Mesylate Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst